Drug Toxicology Monitoring 1, with Confirmation, Oral Fluid
Use
This is a multi‑class oral fluid drug monitoring panel designed to detect recent drug use or misuse through screening of multiple drug classes. It is intended for monitoring compliance and detection of substances including amphetamines, barbiturates, benzodiazepines, buprenorphine, cocaine, fentanyl, heroin metabolite, marijuana, MDMA, meprobamate, methadone, nicotine metabolite, opiates, phencyclidine, tapentadol, tramadol, and zolpidem, with reflex confirmation when screening results exceed cutoffs.
Special Instructions
Not provided.
Limitations
Oral fluid detection windows are shorter than urine; drugs are detectable sooner but cleared more quickly (e.g., detectable 24–50 hours after use). Concentrations may be lower, and collection volume is limited. Results do not indicate dose or timing of ingestion, and must be interpreted in clinical context.
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Result Turnaround Time
2-3 days
Related Documents
For more information, please review the documents below
Specimen
Saliva
Volume
1Â mL oral fluid inserted into 3Â mL buffer tube
Minimum Volume
Not provided
Container
Quantisal™ device
Collection Instructions
Using the standard Quantisal™ collection container, place the swab under the tongue; leave in place until blue dye indicates 1 mL collected; avoid food, drink, gum or tobacco for 10 minutes prior; if mouth not empty, rinse with water and wait 10 minutes before collecting.
Patient Preparation
Avoid food, drink, gum or tobacco for 10Â minutes prior; rinse mouth with up to 4Â oz water if not empty, then wait 10Â minutes.
Causes for Rejection
Non‑Quantisal device; food debris or foreign objects; multiple swabs; missing swab; wand inverted inside tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 72Â hours |
| Refrigerated | 30Â days |
| Frozen | 30Â days |
Other tests from different labs that may be relevant